Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

LabCorp Makes $8 Billion+ Proposal to CRO PPD

  • Post author:Sam
  • Post published:February 5, 2017
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"LabCorp Makes a $8 Billion Proposal to CRO PPD" ALT"LabCorp Makes a $8 Billion Proposal to CRO PPD"February 6, 2017By Alex Keown, BioSpace.com Breaking News StaffBURLINGTON, N.C. <A…

Continue ReadingLabCorp Makes $8 Billion+ Proposal to CRO PPD

Obesity Massachusetts Startup Allurion Banks $19 Million

  • Post author:Sam
  • Post published:February 5, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingObesity Massachusetts Startup Allurion Banks $19 Million

FTC Asks Court to Dismiss Antitrust Claims Against Par, Paddock

  • Post author:Sam
  • Post published:February 3, 2017
  • Post category:Drug Industry Daily

The FTC is asking a Georgia federal court to remove Par Pharmaceuticals and Paddock Laboratories from an antitrust case that alleges the companies delayed the market entry of their AndroGel…

Continue ReadingFTC Asks Court to Dismiss Antitrust Claims Against Par, Paddock

Federal Government Subpoenas Biogen Over the Prices, Rebates of Four Therapies

  • Post author:Sam
  • Post published:February 3, 2017
  • Post category:Drug Industry Daily

The federal government issued a subpoena to Biogen requesting information on prices, rebates and co-assistance programs for four of its therapies, according to an SEC filing by the company. Source:…

Continue ReadingFederal Government Subpoenas Biogen Over the Prices, Rebates of Four Therapies

EMA: Regulatory Guidance Hinders Development of ATMPs

  • Post author:Sam
  • Post published:February 3, 2017
  • Post category:Drug Industry Daily

Advanced therapy medical products are facing several development hurdles, ranging from inadequate regulatory guidance to insufficient funding, the EMA said. Source: Drug Industry Daily

Continue ReadingEMA: Regulatory Guidance Hinders Development of ATMPs

Spain’s AEMPS Suspends Manufacturing in Madrid Facility

  • Post author:Sam
  • Post published:February 3, 2017
  • Post category:Drug Industry Daily

Spain’s medicines and medical devices agency suspended manufacturing at Euro Far Alergi’s Madrid facility citing serious GMP violations. Source: Drug Industry Daily

Continue ReadingSpain’s AEMPS Suspends Manufacturing in Madrid Facility

FDA to Post Unredacted Advisory Committee CVs, Following Public Citizen Lawsuit

  • Post author:Sam
  • Post published:February 3, 2017
  • Post category:Drug Industry Daily

The FDA will no longer redact the CVs of its advisory committee members, in response to a Freedom of Information Act lawsuit filed by Public Citizen last year. Source: Drug…

Continue ReadingFDA to Post Unredacted Advisory Committee CVs, Following Public Citizen Lawsuit

White House Clarifies ‘One In, Two Out’ Regulations Order

  • Post author:Sam
  • Post published:February 3, 2017
  • Post category:Drug Industry Daily

The Office of Management and Budget on Friday clarified President Trump’s new “one in, two out” regulations order, narrowing its scope to significant regulations with an economic impact of over…

Continue ReadingWhite House Clarifies ‘One In, Two Out’ Regulations Order

Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position

  • Post author:Sam
  • Post published:February 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingAsterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position

Catalyst Biosciences To Present At 19th Annual BIO CEO & Investor Conference

  • Post author:Sam
  • Post published:February 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingCatalyst Biosciences To Present At 19th Annual BIO CEO & Investor Conference
  • Go to the previous page
  • 1
  • …
  • 561
  • 562
  • 563
  • 564
  • 565
  • 566
  • 567
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.